Granulomatous lung diseases False-positive results with 18F-FDG-PET and PET-CT in the
setting of cancer have been mostly documented in granulomatous pulmonary diseases and …

We sought to determine whether PET/CT imaging with 68 Ga-citrate could be of value in
distinguishing benign from malignant lung pathology in a setting with a high prevalence of …

Purpose Fluorine-18 fluorodeoxyglucose (18 F-FDG)-PET/computed tomography (CT) is
used for assessment of the extent and activity of disease in patients with inflammatory …

More than one decade ago, introduction of integrated PET/CT scanners changed oncologic
imaging and oncologic patient management profoundly. With these systems, the metabolic …

PET with 18F-FDG has been increasingly applied, predominantly in the research setting, to
study drug effects and pulmonary biology and to monitor disease progression and treatment …

Radiomics analysis quantifies the interpolation of multiple and invisible molecular features
present in diagnostic and therapeutic images. Implementation of 18-fluorine …

Abstract Purpose Dual-tracer, 18 F-fluorodeoxyglucose and 18 F-fluorodeoxythymidine (18
F-FDG/18 F-FLT), dual-modality (positron emission tomography and computed tomography …

2-deoxy-2-(Fluorine-18) fluoro-D-glucose (18 F-FDG) positron emission
tomography/computed tomography (PET/CT) has been used exclusively to diagnose …

Objective The objective of this study was to assess suitability of dual-time-point 18 F-FDG
[(18 F)-fluoro-2-deoxyglucose]-PET imaging for differentiating between malignant and …

PET imaging of fluorodeoxyglucose (FDG) is one of several metabolic imaging procedures
being used to detect various diseases (1). FDG-PET imaging has been demonstrated to be …